Everyone has an innovation policy these days – no prime minister or president is without one. After Barack Obama’s declaration in his State of the Union address that the US faced a new “Sputnik moment”, David Cameron flew to Davos last week to insist that “our biggest ambitions have got to be for innovation”.
To the Guggenheim Museum in New York to watch the launch of The Daily, Rupert Murdoch’s new newspaper – or more accurately newspaper-cum-magazine – for the iPad.
My colleague David Gelles has reviewed the first edition of The Daily here, so I will confine myself to the observation that it looks nice and has lot of moving parts, such as video and slideshows, but lacks urgency.
I increasingly find in using my own iPad that I favour lightweight apps that I know will download quickly, and which are easily navigable, rather than the all-singing all-dancing apps that are long-winded and sluggish.
I am keeping a close eye on my seven New Year predictions – and the fact that The King’s Speech has done so well in Oscar nominations is not a good sign – but one thing which appears to be falling in line is pharmaceutical research.
I stuck my neck out in December and predicted that a large pharma company would drop early-stage research and outsource it instead. Not so far, but Pfizer’s announcement that it will cut back its research operations, including closing its UK research laboratory at Sandwich, is an interesting marker.